169772-25-2 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Current Patent Assignee: PROTAMED, INC. - WO2013/62762, 2013, A1
Location in patent: Page/Page column 35; 36
[2]Current Patent Assignee: PROTAMED, INC. - US9169255, 2015, B2
Location in patent: Page/Page column 25
[3]Baxter,I. et al.
[Journal of the Chemical Society, 1965, p. 3645 - 3660]
[4]Lisowski, Vincent; Enguehard, Cecile; Lancelot, Jean-Charles; Caignard, Daniel-Henri; Lambel, Stephanie; Leonce, Stephane; Pierre, Alain; Atassi, Ghanem; Renard, Pierre; Rault, Sylvain
[Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 16, p. 2205 - 2208]
[5]Tangdenpaisal, Kassrin; Worayuthakarn, Rattana; Karnkla, Supatra; Ploypradith, Poonsakdi; Intachote, Pakamas; Sengsai, Suchada; Saimanee, Busakorn; Ruchirawat, Somsak; Chittchang, Montakarn
[Chemistry - An Asian Journal, 2015, vol. 10, # 4, p. 925 - 937]
Reference: [1]Obase; Nakamizo; Takai; Teranishi; Kubo; Shuto; Kasuya; Shigenobu
[Chemical and Pharmaceutical Bulletin, 1982, vol. 30, # 2, p. 474 - 483]
Reference: [1]Hamada, Akihiko; Yaden, Emily L.; Horng, J. S.; Ruffolo, Robert R.; Patil, Popat N.; Miller, Duane D.
[Journal of Medicinal Chemistry, 1985, vol. 28, # 9, p. 1269 - 1273]
* For details of the synthesis route, please refer to the original source to ensure accuracy.